Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,291Revenue $M375Net Margin (%)16.7Altman Z-Score5.3
Enterprise Value $M1,283EPS $1.8Operating Margin %16.2Piotroski F-Score8
P/E(ttm)20.4Beneish M-Score-2.6Pre-tax Margin (%)14.5Higher ROA y-yY
Price/Book5.010-y EBITDA Growth Rate %4.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %11.0Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow27.8y-y EBITDA Growth Rate %40.8ROA % (ttm)13.8Higher Current Ratio y-yY
Dividend Yield %--PEG1.8ROE % (ttm)27.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M31.3ROIC % (ttm)29.0Gross Margin Increase y-yY

Gurus Latest Trades with CBM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CBMJoel Greenblatt 2015-03-31 Reduce$21.34 - $39.63
($29.57)
$ 41.2439%Reduce 22.55%60,855
CBMJoel Greenblatt 2014-12-31 Buy 0.01%$16.33 - $24.12
($21.29)
$ 41.2494%New holding78,575
CBMJoel Greenblatt 2013-03-31 Sold Out -0.09%$11.27 - $12.79
($11.93)
$ 41.24246%Sold Out0
CBMJoel Greenblatt 2012-12-31 Buy 0.09%$9.34 - $13.96
($11.38)
$ 41.24262%New holding142,352
CBMJoel Greenblatt 2012-09-30 Sold Out -0.02%$9.01 - $13.01
($11.05)
$ 41.24273%Sold Out0
CBMJoel Greenblatt 2012-06-30 Buy 0.02%$5.96 - $9.16
($7.07)
$ 41.24483%New holding30,208
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CBM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CBM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SARGEN GREGORYEVP & CFO 2015-05-11Sell25,000$38.441.43view
SARGEN GREGORYEVP & CFO 2015-02-12Sell25,000$32.6419.45view
Magnini AldoManagin Director-Profarmaco 2015-02-12Sell7,500$32.7519.05view
KLOSK STEVEN MPresident & CEO 2015-02-10Sell45,000$30.3228.59view
Haskel William M.Senior Vice President 2014-11-13Sell7,500$2462.46view
Haskel William M.Senior Vice President 2014-11-06Sell15,000$23.3167.27view
Cavanagh ShawnEVP & COO 2014-09-11Sell56,251$22.5672.83view
KLOSK STEVEN MPresident & CEO 2014-09-03Sell126,257$22.0177.15view
Haskel William M.Senior Vice President 2014-09-02Sell9,400$21.9477.71view
KLOSK STEVEN MPresident & CEO 2014-08-19Sell4,702$2277.23view

Press Releases about CBM :

    Quarterly/Annual Reports about CBM:

    News about CBM:

    Articles On GuruFocus.com
    Cambrex Corp. Reports Operating Results (10-Q) Aug 04 2010 
    Cambrex Corp. Reports Operating Results (10-Q) May 05 2010 
    Does Cambrex Corporation Have Earnings Persistence? Apr 28 2010 
    Cambrex Corp. Reports Operating Results (10-Q) Nov 04 2009 

    More From Other Websites
    Cambrex To Present At UBS Global Healthcare Conference May 11 2015
    Cambrex To Present At UBS Global Healthcare Conference May 11 2015
    10-Q for Cambrex Corp. May 03 2015
    Growth Names Pressured As IBD 50 Slumps 4% For Week May 01 2015
    Cambrex Corp Earnings Call scheduled for 8:30 am ET today May 01 2015
    CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 01 2015
    Cambrex posts 1Q profit May 01 2015
    Cambrex posts 1Q profit May 01 2015
    Cambrex Reports First Quarter 2015 Financial Results May 01 2015
    Q1 2015 Cambrex Corp Earnings Release - Before Market Open May 01 2015
    Cambrex Reports First Quarter 2015 Financial Results May 01 2015
    CAMBREX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Apr 30 2015
    Cambrex To Announce First Quarter 2015 Financial Results On May 1, 2015 Apr 29 2015
    Cambrex To Announce First Quarter 2015 Financial Results On May 1, 2015 Apr 29 2015
    Cambrex to Present at the Deutsche Bank 40th Annual Healthcare Conference Apr 29 2015
    Cambrex to Present at the Deutsche Bank 40th Annual Healthcare Conference Apr 29 2015
    The IBD 50 in an ETF Wrapper Apr 22 2015
    New Innovator IBD 50 ETF Makes Strong Debut - ETF News And Commentary Apr 22 2015
    Amgen Upgraded to Strong Buy, Perfect for Your Portfolio - Analyst Blog Apr 13 2015
    5 IBD 50s Offer Triple-Digit Earnings Growth Views Apr 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK